Buscar Files Unaudited FY2026 Annual Report, Expands PCAOB Audit
Buscar Company filed an unaudited annual report for fiscal 2026 and expanded the scope of its ongoing PCAOB audit to fiscal years 2025 and 2026.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
17 results loaded, newest first. End of these results.
Buscar Company filed an unaudited annual report for fiscal 2026 and expanded the scope of its ongoing PCAOB audit to fiscal years 2025 and 2026.
Annual Report & CG Report Amended Announcements Please refer to the earlier announcement reference number: DCS-30042026-00222 Thong Guan Industries Berhad Annual Report for Financial Year Ended 31 Dec 2025 Subject Annual Report & CG Report — 2025 Please refer attachment below. Attachments THOG01-AddendumAR2025.pdf ( )
Senseonics Holdings (AMEX: SENS ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Senseonics Holding
Agenus said Zack Armen will take part in a fireside chat and one-on-one investor meetings at Chardan's 10th Annual Healthcare Conference on Oct. 20 in New York.
Insulet (NASDAQ: PODD ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Insulet Corporation reported a 23% year-over-year revenue
Company says its Annual Report & CG Report for the financial year ended 31 Dec 2025 has been amended, referring to earlier announcement reference DCS-23042026-00055 and posting addendum and Shariah screening financial data attachments.
The company said unaudited interim results for the six months to 30 June 2026 showed cash reserves of £7.1 million and progress on Malaysian projects and financing.
The brewer said revenue fell to £162.6m in the 52 weeks to 27 June 2026, while underlying EBITDA and underlying profit before tax rose. It also said Richard Oldfield will retire as chairman after the 30 October AGM, with Jonathan Neame to become executive chairman and Mark Rider managing director.
Takeda said new Phase 3 LATITUDE Atlas data showed zasocitinib was statistically superior to deucravacitinib across primary and key secondary endpoints. The company also cited durable skin clearance and no new safety signals.
The company reported results for the period ended 31 May 2026 and said CEO Jerry Randall intends to retire from the role. It also highlighted revenue growth, a share buyback programme and recent disposals and acquisitions.
Tandem Diabetes Care said Tandem Mobi is now available in 12 countries outside the United States, with orders and shipping starting for eligible customers. Markets include Belgium, the Czech Republic, Denmark, Finland, Germany, Israel, Italy, Luxembourg, Spain, Sweden, Switzerland and the UK.
For best results when printing this announcement, please click on link below: RNS Number: 0602W India Capital Growth Fund Limited 24 September 2026 INDIA CAPITAL GROWTH FUND LIMITED Interim Results for the six months ended 30 June 2026 24 September 2026, London - India Capital Growth Fund ("ICGF" or "the Company"), the
For best results when printing this announcement, please click on link below: Generation Mining Closes “Bought Deal” Public Offering and Concurrent Private Placement for Gross Proceeds of $240 Million Not For Distribution To U.s. Newswire Services Or Dissemination In The United States Further to its news release dated
Alkermes announced positive topline results from a Phase 1b proof-of-concept study evaluating its investigational orexin 2 receptor agonist, ALKS 7290, in adults with attention-deficit hyperactivity disorder (ADHD). The drug demonstrated clinically meaningful improvements in ADHD symptoms.
On Thursday, Albemarle (NYSE: ALB ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Albemarle Corporation reported Q2 2026 net sales
On Monday, AstraZeneca (NASDAQ: AZN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary AstraZeneca reported a 6% growth in total revenue for the fi
InspireMD (NASDAQ: NSPR ) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available